ClinConnect ClinConnect Logo
Search / Trial NCT01918579

C Reactive Protein (CRP) Intervention to Reduce Inappropriate Antibiotic Prescriptions in the Primary Healthcare Setting

Launched by OXFORD UNIVERSITY CLINICAL RESEARCH UNIT, VIETNAM · Aug 6, 2013

Trial Information

Current as of July 02, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients, aged 6 to 65 years, that visit one of the 10 selected primary healthcare centers
  • Suspected to have acute respiratory tract infection (ARI) by treating physician
  • Informed consent
  • Exclusion Criteria:
  • Severe respiratory disease as determined by treating doctor
  • Any disease or symptom requiring hospital referral as determined by treating doctor
  • Immunosuppressed patients (e.g. HIV, long term steroid use)
  • Suspicion of tuberculosis
  • Evidence of acute or chronic liver disease (e.g. hepatitis or cirrhosis due to any cause)
  • Past medical history of: neoplastic disease, congestive cardiac failure, chronic obstructive pulmonary disease, insulin-dependent diabetes or renal disease
  • Pregnancy
  • No access to telephone
  • Not able to come for follow up visit on day 3 or 4.
  • Already taking antibiotics at the time of presentation
  • Symptoms present for more than 2 weeks
  • Presence of any sign of severe diseases as defined by the British Thoracic Society modified CRP-65 system for severity scoring of pneumonia in primary care.
  • For children (Age ≥ 6 years and \< 16 years) additional exclusion criteria include: Tachypnea, signs of chest wall in drawing, reduced consciousness, confusion, dehydration, hypothermia, severe malnutrition, unable to feed or drink, vomiting, and convulsions.

About Oxford University Clinical Research Unit, Vietnam

The Oxford University Clinical Research Unit (OUCRU) in Vietnam is a leading institution dedicated to advancing medical knowledge and improving health outcomes through innovative clinical research. As part of a global network, OUCRU focuses on infectious diseases and public health challenges, leveraging its expertise to conduct high-quality clinical trials and epidemiological studies. With a commitment to ethical research practices and collaboration with local and international partners, OUCRU aims to translate scientific findings into effective interventions, contributing to the health and well-being of communities in Vietnam and beyond.

Locations

Hanoi, , Vietnam

Patients applied

0 patients applied

Trial Officials

Heiman FL Wertheim, M.D,Ph.D

Study Director

Oxford University Clinical Research Unit

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials